Rifabutin Capsule
Product Images NDC 59762-1350

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rifabutin (NDC 59762-1350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rifabutin 01)

Chemical structure diagram of rifabutin, the active ingredient in Rifabutin capsules, 150 mg, by Mylan Pharmaceuticals Inc. The image shows the molecular framework with atoms and bonds typical of rifabutin's chemical formula.*

FDA Label Image

Logo (Rifabutin 02)

FDA Label Image

Principal Display Panel (150 mg Capsule Bottle Label)

Label for Rifabutin capsules, USP, 150 mg, a human prescription drug by Mylan Pharmaceuticals Inc. The label indicates a package size of 100 capsules. It includes storage instructions, dosage notes stating each capsule contains 150 mg rifabutin, and product distribution information by Greenstone LLC. The label also features a barcode and NDC 59762-1350-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.